Bridging Cancer and COVID‐19: The Complex Interplay of ACE2 and TMPRSS2
ABSTRACT The coronavirus disease 2019 (COVID‐19) pandemic presents heightened risks for cancer patients, who are more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and severe outcomes due to immunosuppression from both the malignancy and anticancer therapies....
Saved in:
| Main Authors: | Xuerui Tang, Liuzhi Lu, Xiaoping Li, Panpan Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70829 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the potential mechanisms of impairment on genitourinary system associated with coronavirus disease 2019 infection: Bioinformatics and molecular simulation analyses
by: Kai Zhao, et al.
Published: (2023-07-01) -
SARS-CoV-2 effects in the genitourinary system and prospects of sex hormone therapy
by: Kuangzheng Liu, et al.
Published: (2021-07-01) -
The Renin–Angiotensin System Modulates SARS-CoV-2 Entry via ACE2 Receptor
by: Sophia Gagliardi, et al.
Published: (2025-07-01) -
Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01) -
A Meta-Analysis of the Impact of Using Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) on Mortality, Severity, and Healthcare Resource Utilization in Patients with COVID-19
by: Ruijuan Li, et al.
Published: (2025-02-01)